with flowcytometry, cytogenetic and molecular biology findings
Novartis IBA FM MU

Acute myeloid leukaemia with t(8;21)(q22;q22); RUNX-RUNX1T1

BM MGG (1000×)

Numerous agranular and granular myeloblasts are present in the bone marrow. Auer rods are also frequently found (blue arrow): they usually have a quite typical morphology – seen as single, long and sharp rods with tapered ends. Granulocytic lineage dysplasia is the second finding; it means an abnormal nuclear segmentation (red arrow) and cytoplasmic staining abnormalities – pink-coloured cytoplasma with the ring of basophilic cytoplasma at the periphery of the cell (black arrows).

G-banded partial karyotype of translocation t(8;21)(q22;q22)

This partial karyotype demonstrates translocation t(8;21)(q22;q22). Red arrows indicate derivative chromosomes 8 and 21. Breakpoint sites are indicated by black arrows. The t(8;21)(q22;q22) results in a juxtaposition of the RUNX1T1 gene (formerly known as ETO) located on 8q22 and the RUNX1 gene (formerly known as AML1) located on 21q22. This juxtaposition generates the fusion gene RUNX1-RUNX1T1 located on the der(8) chromosome.

Fluorescence in situ hybridisation (FISH) of RUNX1-RUNX1T1 fusion

Fluorescence in situ hybridisation (FISH) of the RUNX1-RUNX1T1 fusion was performed on interphase cells and chromosomes. A dual-colour, dual-fusion FISH probe was used. The orange-labelled probe spans the breakpoint at 21q22.1 RUNX1 (formerly AML1; indicated by a red arrow), whereas the green-labelled probe spans the breakpoint at 8q21.3-22.1 RUNX1T1 (formerly ETO; indicated by a green arrow). The translocation fuses RUNX1 with RUNX1T1 to produce a RUNX1-RUNX1T1 fusion gene located on the derivative chromosome 8 (green-red signal indicated by a yellow arrow).

Agarose gel electropherogram for RUNX-RUNX1T1 transcript detection

A: Nested PCR – first round of amplification using outer primers. The figure shows that the PCR amplification product about the size 395 bp corresponds to the RUNX1-RUNX1T1 transcript (e5e2) in two samples of the patient (red arrow); the blue arrow marks the PCR product of positive control, whereas the green arrow indicates no template control (NTC). On the left, DNA size marker is applied (black arrow).

B: Nested PCR – second round of amplifications using inner primers. The figure shows that the PCR amplification product about the size 260 bp corresponds to the RUNX1-RUNX1T1 transcript (e5e2) in two samples of the patient (red arrow); the blue arrow marks the PCR product of positive control, whereas the green arrow indicates no template control (NTC). On the left, DNA size marker is applied (black arrow).

Schematic representation of RUNX1, RUNXT1 and RUNX1-RUNX1T1 genes

A: Genomic organisation of the RUNX1 loci. The red arrow indicates a breakpoint between exons e5 and e6 of the RUNX1 gene.

B: Genomic organisation of the RUNX1T1 loci. The blue arrow indicates a typical breakpoint within the RUNX1T1 gene – between exons e1 and e2.

C: Schematic diagram of the RUNX1-RUNX1T1 fusion gene. The black arrow marks a junction between the RUNX1 (behind exon e5) and RUNX1T1 (in front of exon e2) genes.

Atlas of Haematological Cytology [online]. 2016 [cit. 2024-4-20]. Available from WWW: http://www.leukemia-cell.org/atlas.

2024 CELL - Atlas of Haematological Cytology | site map